Trial intelligence / Profile preview

Immune Response to FluMist vs Fluzone in Children 5-9

NCT00138385Phase 4Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Start
Aug 2005
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of live attenuated influenza vaccine, Fluzone Trivalent in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2005; status: completed.

02

Drugs

live attenuated influenza vaccineFluzone Trivalent
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00138385.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00138385.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call